London Global Cancer Week 2026 opened on Monday, November 2, bringing the international cancer community together through November 6 to examine why access to cancer prevention, diagnosis, treatment and care remains so uneven around the world, according to Oncodaily.
The week is being framed around the theme "Global Partnerships for Equitable Cancer Care." The Coalition for Access to NCD Medicines and Products, which is associated with the event, said the theme reflects its own view that closing cancer gaps depends on cooperation spanning different sectors, professional fields and national borders, Oncodaily reports.
Why it matters
Cancer is among the leading causes of death globally, yet the chances of surviving it, obtaining medicines, and being screened vary widely between and within countries. According to the Coalition, those differences are not accidental. They are influenced by policy choices, levels of investment, and whether medicines and diagnostics that meet quality standards actually reach the patients who need them.
That framing places the week's discussions well beyond clinical research alone. It points to the systems that determine whether a diagnosis leads to treatment, and whether treatment leads to survival. Oncodaily reports that the Coalition sees collaboration across sectors and disciplines as essential to addressing these disparities.
The choice of theme also signals that the organisers view inequity as a shared problem rather than one confined to low-income settings. Survival rates, access to medicines and screening uptake are described by the Coalition as deeply unequal, shaped by decisions made in health policy, financing and supply.
A platform for practitioners and advocates
The programme has drawn speakers from the global oncology community. Among them is Olubukola Ayodele, who said she was excited to be speaking at the 2026 edition, according to Oncodaily. Her participation reflects the event's role as a meeting point for clinicians, researchers, advocates and others working on cancer care across different health systems.
The gathering runs across five days, from November 2 to November 6. Oncodaily's coverage describes it as an annual moment when the global cancer community takes stock of one of the most stubborn problems in health: that the quality of cancer care a person receives still depends heavily on where they live and what their health system can afford.
The access question behind the theme
The Coalition's stated focus on NCD medicines and products places the availability of treatments and diagnostics at the centre of the week's agenda. Its summary of the issue notes that unequal outcomes are tied to whether quality-assured medicines and diagnostics reach the people who need them — a supply and delivery question as much as a scientific one.
That emphasis connects the London discussions to broader efforts on non-communicable diseases, where cancer sits alongside other conditions that require sustained treatment and reliable access to essential products. By naming partnerships in its theme, the Coalition is arguing that no single country, institution or discipline can resolve these gaps alone.
Oncodaily reports that the week's sessions are intended to address inequitable access to prevention, diagnosis, treatment and care — the full pathway rather than any single stage. That scope means conversations are likely to touch on screening programmes, the point of diagnosis, the availability of medicines, and the continuity of care that patients need after treatment begins.
What to watch
The week runs through Friday, November 6. Watch for how the partnerships discussed in London translate into commitments on medicines, diagnostics and screening — and whether the theme of equitable care produces concrete follow-through after the event closes.
